EMA — authorised 6 June 2019
- Marketing authorisation holder: PFIZER EUROPE MA EEIG
- Status: approved
🇪🇺 Lorbrena in European Union
EMA authorised Lorbrena on 6 June 2019
Marketing authorisation
Lorbrena in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Lorbrena approved in European Union?
Yes. EMA authorised it on 6 June 2019.
Who is the marketing authorisation holder for Lorbrena in European Union?
PFIZER EUROPE MA EEIG holds the EU marketing authorisation.